IP assets of bio-pharmaceuticals delivery specialists brought to market by Metis Partners

IP assets of bio-pharmaceuticals delivery specialists brought to market by Metis Partners

The IP assets of a recognised leader in the bioformulation and drug delivery industry, XstalBio Limited, which is behind CentuRecon – a patent-backed reconstitution technology that has the potential to revolutionise the preparation of high concentration protein solutions, are being offered for sale by Metis Partners, the award-winning, commercial intellectual property consulting firm. Established as […]

read more

IP assets of bio-pharmaceuticals delivery specialists brought to market by Metis Partners

IP assets of bio-pharmaceuticals delivery specialists brought to market by Metis Partners

The IP assets of a recognised leader in the bioformulation and drug delivery industry, XstalBio Limited, which is behind CentuRecon – a patent-backed reconstitution technology that has the potential to revolutionise the preparation of high concentration protein solutions, are being offered for sale by Metis Partners, the award-winning, commercial intellectual property consulting firm. Established as […]

read more

XstalBio IP Asset Sale

XstalBio IP Asset Sale

Metis Partners is offering an excellent opportunity to purchase the IP assets behind a leading bioformulation and drug delivery company with proprietary technologies that are applied to the delivery of bio-pharmaceuticals to patients in the most efficient manner. SALE All offers and requests for more information should be submitted by email directly to Aylin Dzhafer […]

read more